UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practiceAaron Lee, Adnan Tufail, Catherine Egan et al.|British Journal of Ophthalmology|2017Cited by 47